|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
90,552,000 |
Market
Cap: |
3.31(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$18.07 - $44.07 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 8 |
Insider 3/6 Months : 8.6 |
|
Guru Rank Number : 538 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. Co. has the following products, Translarna (ataluren) and Emflaza® (deflazacort), for the treatment of Duchenne muscular dystrophy, a rare, life threatening disorder. Co.'s gene therapy product candidates for rare monogenic diseases that affect the central nervous system (CNS) include PTC- Aromatic L-Amino Acid Decarboxylase (AADC) for the treatment of AADC deficiency, a rare CNS disorder arising from reductions in the enzyme AADC that results from mutations in the dopa decarboxylase gene.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
7,700 |
7,700 |
7,700 |
Total Buy Value |
$0 |
$198,736 |
$198,736 |
$198,736 |
Total People Bought |
0 |
1 |
1 |
1 |
Total Buy Transactions |
0 |
1 |
1 |
1 |
Total Shares Sold |
26,156 |
72,347 |
84,013 |
300,515 |
Total Sell Value |
$921,768 |
$2,218,045 |
$2,683,017 |
$13,658,321 |
Total People Sold |
4 |
9 |
10 |
16 |
Total Sell Transactions |
6 |
28 |
29 |
90 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Souza Marcio |
Chief Operating Officer |
|
2019-12-23 |
4 |
OE |
$11.23 |
$1,094,544 |
D/D |
75,881 |
68,221 |
|
- |
|
Peltz Stuart Walter |
Chief Executive Officer |
|
2019-12-03 |
4 |
AS |
$50.00 |
$1,123,150 |
I/I |
(22,463) |
18,676 |
|
- |
|
Peltz Stuart Walter |
Chief Executive Officer |
|
2019-12-03 |
4 |
OE |
$10.85 |
$265,169 |
I/I |
18,981 |
26,332 |
|
- |
|
Boulding Mark Elliott |
Exec. VP and CLO |
|
2019-07-05 |
4 |
AS |
$44.45 |
$685,097 |
D/D |
(15,312) |
29,524 |
|
- |
|
Boulding Mark Elliott |
Exec. VP and CLO |
|
2019-07-05 |
4 |
OE |
$11.23 |
$231,279 |
D/D |
15,312 |
33,899 |
|
- |
|
Utter Christine Marie |
SVP, Finance & CAO |
|
2019-07-01 |
4 |
AS |
$45.15 |
$590,143 |
D/D |
(13,071) |
4,937 |
|
- |
|
Utter Christine Marie |
SVP, Finance & CAO |
|
2019-07-01 |
4 |
OE |
$18.01 |
$271,968 |
D/D |
13,071 |
14,234 |
|
- |
|
Boulding Mark Elliott |
Exec. VP and CLO |
|
2019-07-01 |
4 |
AS |
$45.00 |
$4,684,140 |
D/D |
(104,092) |
29,524 |
|
- |
|
Boulding Mark Elliott |
Exec. VP and CLO |
|
2019-07-01 |
4 |
OE |
$10.85 |
$2,521,639 |
D/D |
104,092 |
47,024 |
|
- |
|
Utter Christine Marie |
SVP, Finance & CAO |
|
2019-06-28 |
4 |
AS |
$45.00 |
$44,460 |
D/D |
(988) |
4,937 |
|
- |
|
Utter Christine Marie |
SVP, Finance & CAO |
|
2019-06-28 |
4 |
OE |
$18.01 |
$20,557 |
D/D |
988 |
5,640 |
|
- |
|
Boulding Mark Elliott |
Exec. VP and CLO |
|
2019-06-28 |
4 |
AS |
$45.00 |
$3,490,875 |
D/D |
(77,575) |
29,524 |
|
- |
|
Boulding Mark Elliott |
Exec. VP and CLO |
|
2019-06-28 |
4 |
OE |
$10.85 |
$880,723 |
D/D |
77,575 |
30,664 |
|
- |
|
Souza Marcio |
Chief Operating Officer |
|
2019-06-03 |
4 |
S |
$40.38 |
$221,686 |
D/D |
(5,490) |
58,664 |
|
- |
|
Hill Emily Luisa |
Chief Financial OfficerOfficer |
|
2019-05-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,605 |
|
- |
|
Utter Christine Marie |
Principal Financial Officer |
|
2019-03-05 |
4 |
AS |
$34.70 |
$1,003,824 |
D/D |
(28,709) |
4,937 |
|
- |
|
Utter Christine Marie |
Principal Financial Officer |
|
2019-03-05 |
4 |
OE |
$10.85 |
$328,852 |
D/D |
26,200 |
11,237 |
|
- |
|
Schmertzler Michael |
Director |
|
2019-01-25 |
4 |
B |
$30.20 |
$1,999,995 |
I/I |
66,225 |
1,386,594 |
2.1 |
- |
|
Almstead Neil Gregory |
Chief Technical Ops Officer |
|
2019-01-22 |
4 |
A |
$0.00 |
$0 |
I/I |
570 |
6,219 |
|
- |
|
Souza Marcio |
Chief Operating Officer |
|
2019-01-22 |
4 |
A |
$0.00 |
$0 |
I/I |
1,925 |
4,667 |
|
- |
|
Peltz Stuart Walter |
Chief Executive Officer |
|
2019-01-22 |
4 |
A |
$0.00 |
$0 |
I/I |
4,620 |
22,158 |
|
- |
|
Utter Christine Marie |
Principal Financial Officer |
|
2019-01-07 |
4 |
S |
$34.75 |
$10,321 |
D/D |
(297) |
7,446 |
|
- |
|
Souza Marcio |
Chief Operating Officer |
|
2019-01-07 |
4 |
S |
$34.75 |
$2,884 |
I/I |
(83) |
2,742 |
|
- |
|
Peltz Stuart Walter |
Chief Executive Officer |
|
2019-01-07 |
4 |
S |
$34.75 |
$25,993 |
I/I |
(748) |
17,538 |
|
- |
|
Peltz Stuart Walter |
Chief Executive Officer |
|
2019-01-07 |
4 |
S |
$34.75 |
$61,299 |
D/D |
(1,764) |
24,882 |
|
- |
|
524 Records found
|
|
Page 16 of 21 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|